JPRN-UMIN000009807已完成2 期
A phase II study of weekly paclitaxel for advanced or recurrent esophageal cancer - Second line treatment using weekly paclitaxel for esophageal cancer
Medical Oncology, Hirosaki University Graduate School of Medicine0 个研究点目标入组 30 人开始时间: 2013年1月21日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •severe bone marrow suppression active infection uncontrolled comorbidities acute inflammatory disease interstitial pneumonia or pulmonary fibrosis symptomatic metastases of the central nervous system with a history of allergic reaction to polyoxyethylene-castor oil under administration of disulfiram, cyanamide and procarbazine hydrochloride pregnant or nursing woman any patients judged by the investigator to be unfit to participate in the study
研究者
相似试验
已完成
2 期
Phase II study of weekly paclitaxel (wP) followed by doxorubicin plus paclitaxel (AP) as neo-adjuvant chemotherapy for triple negative Breast Cancer (WePAP)Primary breast cancerJPRN-UMIN000001205Saitama Breast Cancer Clinical Study Group (SBCCSG)63
已完成
2 期
A phase 2 study of weekly Nab-Paclitaxel followed by FEC (Fluorouracil, Epirubicin, Cyclophosphamide) as primary therapy for operable breast cancerBreast cancerJPRN-UMIN000007510ahanishi Clinic30
已完成
2 期
A phase II study of weekly paclitaxel in patients with advanced or recurrent esophageal cancer who had previously received docetaxel-containing chemotherapyAdvanced or recurrent esophageal cancerJPRN-UMIN000019230niversity of Miyazaki Hospital25
招募中
不适用
Phase II study of weekly Nab-paclitaxel followed by FEC as Neoadjuvant Chemotherapy for Breast CancerBreast cancerJPRN-UMIN000005979Wakayama Medical University50
已完成
2 期
Assessment of efficacy of weekly paclitaxel chemotherapy in ovarian cancersAdvanced Ovarian Cancer.Malignant neoplasm of ovaryIRCT2017050333789N1Taleghani Hospital- Shahid Beheshti University of Medical Sciences14